Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials

Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials

Background:Patient characteristics may predict the progression of Alzheimer’s disease (AD) and may moderate the effects of donepezil. Objective:To build a personalized prediction model for patients with AD and to estimate patient-specific treatment effects of donepezil, using individual patient char...

Full description

Bibliographic Details
Main Authors:	Yoshida, K, Seo, M, Luo, Y, Sahker, E, Cipriani, A, Leucht, S, Iwatsubo, T, Efthimiou, O, Furukawa, TA
Format:	Journal article
Language:	English
Published:	IOS Press 2022

Similar Items

Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
by: Levine, SZ, et al.
Published: (2022)

Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician’s Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: evidence based on individual participant data from five randomized clinical trials of donepezil
by: Samara, M, et al.
Published: (2021)

Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
by: Stephen Z. Levine, et al.
Published: (2021-01-01)

Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
by: Levine, SG, et al.
Published: (2021)

Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies
by: Samara, MT, et al.
Published: (2017)

Shortening the Alzheimer’s disease assessment scale cognitive subscale
by: Stephen Z. Levine, et al.
Published: (2024-01-01)

Donepezil for dementia due to Alzheimer's disease
by: Birks, J, et al.
Published: (2018)

Donepezil for the treatment of agitation in Alzheimer's disease.
by: Howard, R, et al.
Published: (2007)

Cognitive-behavioral analysis system of psychotherapy, drug, or their combination for persistent depressive disorder: personalizing the treatment choice using individual participant data network meta-regression
by: Furukawa, T, et al.
Published: (2018)

Dismantling, personalising and optimising internet cognitive–behavioural therapy for depression: a study protocol for individual participant data component network meta-analysis
by: Furukawa, T, et al.
Published: (2018)

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta‐analysis
by: Furukawa, T, et al.
Published: (2018)

Peran donepezil dalam terapi penyakit alzheimer
by: Perpustakaan UGM, i-lib
Published: (1999)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
by: Howard, R, et al.
Published: (2012)

Galantamine vs donepezil in the treatment of Alzheimer's disease.
by: Goldlist, B, et al.
Published: (2003)

Initial Severity of Schizophrenia and Efficacy of Antipsychotics: Participant-Level Meta-analysis of 6 Placebo-Controlled Studies.
by: Furukawa, T, et al.
Published: (2015)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
by: Howard, R, et al.
Published: (2012)

Donepezil Treatment for Alzheimer’s Disease in Chronic Dialysis Patients
by: Konstantina G. Yiannopoulou, et al.
Published: (2019-09-01)

Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
by: Serge Gauthier
Published: (2020-12-01)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Pratt, R, et al.
Published: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Perdomo, C, et al.
Published: (2003)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
by: Wilcock, G, et al.
Published: (2001)

The Kilim plot: a tool for visualizing network meta-analysis results for multiple outcomes
by: Seo, M, et al.
Published: (2020)

Research progress of donepezil for treating mild to moderate Alzheimer's disease
by: Xin-xin LI, et al.
Published: (2017-02-01)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
by: Whitehead, A, et al.
Published: (2004)

Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data
by: Furukawa, TA, et al.
Published: (2021)

Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis.
by: Ruey Chen, et al.
Published: (2017-01-01)

Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis
by: Jiaxun Guo, et al.
Published: (2020-11-01)

Cognitive-behavioural analysis system of psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis
by: Furukawa, TA, et al.
Published: (2016)

Cognitive restructuring, behavioral activation and cognitive behavioral therapy in the treatment of adult depression: a network meta-analysis
by: Ciharova, M, et al.
Published: (2021)

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
by: Wilcock, G, et al.
Published: (2003)

Obsessive–compulsive disorder induced by donepezil in a patient with Alzheimer's disease
by: Kohei Echizen, et al.
Published: (2024-06-01)

Evaluation the effect of Donepezil on Cerebral Blood Flow Velocity in Alzheimer's Disease
by: Abbas Ghorbani, et al.
Published: (2010-11-01)

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
by: Zou Heng, et al.
Published: (2011-05-01)

Multi-target directed donepezil-like ligands for Alzheimer's disease
by: Mercedes eUnzeta, et al.
Published: (2016-05-01)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
by: Irene Pachón-Angona, et al.
Published: (2019-01-01)

Donepezil improves vascular function in a mouse model of Alzheimer’s disease
by: Carolina Pellegrini, et al.
Published: (2021-12-01)

Effect of Donepezil and Hyoscyamoside on Improving Spatial Memory in Rats With Alzheimer\'s Disease
by: Fatemeh Heidari Soureshjani, et al.
Published: (2020-09-01)

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
by: E Loveman, et al.
Published: (2006-01-01)

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
by: Dan-Dan Li, et al.
Published: (2019-05-01)

Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.
by: Spineli, L, et al.
Published: (2013)